Vistin Pharma ASA: First quarter 2022 financial results
April 27, 2022 01:45 ET
|
Vistin Pharma ASA
Oslo, Norway, 27th of April 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the first quarter 2022 Revenue in first quarter ended at MNOK 33 compared...
Vistin Pharma ASA: Invitation to Q1 2022 conference call
April 20, 2022 07:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 20 April 2022 Vistin Pharma ASA will release its first quarter 2022 results on Wednesday 27th of April 2022. Vistin Pharma will host a conference call for all shareholders and...
Vistin Pharma ASA: Fourth quarter 2021 financial results
February 17, 2022 01:40 ET
|
Vistin Pharma ASA
Oslo, Norway, 17th of February 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter 2021 Revenue in fourth quarter ended at MNOK 78...
New interim CEO
February 16, 2022 09:45 ET
|
Vistin Pharma ASA
CEO Kjell-Erik Nordby is currently on sick-leave, and the Board in Vistin Pharma, with effect from today, has appointed Magnus Tolleshaug as interim CEO. Magnus Tolleshaug has been employed in Vistin...
Vistin Pharma ASA: Invitation to Q4 2021 conference call
February 08, 2022 08:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 8 February 2022 Vistin Pharma ASA will release its fourth quarter 2021 results on Thursday 17th of February 2022. Vistin Pharma will host a conference call for all shareholders and...
Vistin Pharma ASA: Mandatory notification of trade
October 29, 2021 08:39 ET
|
Vistin Pharma ASA
Pactum AS, a closely related party to the primary insider and board member Espen W. Marcussen in Vistin Pharma ASA, has on 29 October 2021 sold 3,519,733 shares in Vistin Pharma ASA at NOK 19.50 per...
Vistin Pharma ASA: Third quarter 2021 financial results
October 28, 2021 01:45 ET
|
Vistin Pharma ASA
Oslo, Norway, 28th of October 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter 2021 Revenue in third quarter ended at MNOK...
Vistin Pharma ASA: Invitation to Q3 2021 conference call
October 21, 2021 06:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 21 October 2021 Vistin Pharma ASA will release its third quarter 2021 results on Thursday 28th of October 2021. Vistin Pharma will host a conference call for all shareholders and...
Mandatory notification of trade in Vistin Pharma ASA
September 14, 2021 02:34 ET
|
Vistin Pharma ASA
Tycoon Industrier AS has on 13 September 2021 sold 784,280 shares in Vistin Pharma ASA at NOK 21.1 per share. Ferncliff Listed DAI AS has on 13 September 2021 purchased 784,280 shares in Vistin...
Vistin Pharma ASA: Second quarter and first half 2021 financial results
August 19, 2021 01:45 ET
|
Vistin Pharma ASA
Oslo, Norway, 19th of August 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter 2021 Revenue in second quarter ended at MNOK 66.8...